Synapse - Brian Kushner

Results (313)

Re-thinking transplant for neuroblastoma

Editorial

Kushner, B. H.
Pediatric Blood and Cancer (2021)

Mandibular metastases in neuroblastoma: Outcomes and dental sequelae

Journal Article

Singh, A.; Modak, S.; Solano, A. K.; Kushner, B. H.; Wolden, S.; Huryn, J.; Estilo, C. L.
Pediatric Blood and Cancer (2021)

Fulltext@MSK | Save

Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression

Journal Article

Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma

Meeting Abstract

Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
Cancer Research (2020)

Fulltext@MSK | Save

Efficacy and updated safety results from pivotal phase II trial 201 of naxitamab (Hu3F8): A humanized GD2-targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB)

Meeting Abstract

Mora, J.; Chan, G. C.; Morgenstern, D. A.; Nysom, K.; Bear, M.; Worsaae Dalby, L.; Lisby, S.; Kushner, B. H.
Annals of Oncology (2020)

Fulltext@MSK | Save

Pivotal trial 201 data on outpatient administration of naxitamab (Hu3F8), a humanized GD2 targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB)

Meeting Abstract

Morgenstern, D. A.; Mora, J.; Chan, G. C.; Nysom, K.; Bear, M.; Worsaae Dalby, L.; Lisby, S.; Kushner, B. H.
Annals of Oncology (2020)

Fulltext@MSK | Save

International, multicenter phase II trial with humanized anti-GD2 monoclonal antibody naxitamab for treatment of refractory/relapsed high-risk neuroblastoma: Efficacy and safety data

Meeting Abstract

Mora, J.; Chan, G.; Morgenstern, D.; Nysom, K.; Bear, M.; Dalby, L. W.; Lisby, S.; Kushner, B.
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save

Reactive regional lymphadenopathy associated with neuroblastoma immunotherapy

Meeting Abstract

Lentini-Rivera, A.; Kushner, B.; Modak, S.; Price, A.
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save

Surveillance for early detection of neuroblastoma central nervous system relapse

Meeting Abstract

Modak, S.; Kushner, B.; Cheung, N. K.; Kramer, K.
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save

High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial

Meeting Abstract

Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
Pediatric Blood and Cancer (2020)

Fulltext@MSK | Save